Form 4: Summit Therapeutics CFO Reports Stock Transaction

Sentiment:

Insider Transaction (Form 4)


Manmeet Singh Soni, COO and CFO and a Director of Summit Therapeutics Inc., reported multiple transactions in common stock on November 16, 2026.

Summary

  • Option exercise/conversion: acquired 100,000 Common Stock at $1.37 ($137,000) on November 16, 2026; holds 3,224,375 after (Direct).
  • Option exercise/conversion: disposed of 100,000 Stock Option (right to buy) on November 16, 2026; holds 100,000 after (Direct).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.

Insider Transactions

Manmeet Singh Soni — Director, Officer (COO and CFO)

DateTransactionSecuritySharesPriceValueHeld After
2026-11-16Option exercise/conversionCommon Stock100,000$1$137.0K3,224,375
2026-11-16Option exercise/conversionStock Option (right to buy)100,000——100,000

Key Dates

DateDescription
2026-11-16Option exercise/conversion (100,000 shares)
2026-11-16Option exercise/conversion (100,000 shares)

Keywords

insider transaction, Form 4, SMMT, Summit Therapeutics Inc., neutral, Manmeet Singh Soni

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.